These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24263309)

  • 41. The integrated treatment of peritoneal carcinomatosis. A preliminary experience.
    Cavaliere F; Di Filippo F; Cosimelli M; Aloe L; Arcuri E; Anzà M; Callopoli A; Di Lauro L; Morace E; Botti C; Natoli S; Tedesco M; Giunta S; Cavaliere R
    J Exp Clin Cancer Res; 1999 Jun; 18(2):151-8. PubMed ID: 10464701
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modest advances in survival for patients with colorectal-associated peritoneal carcinomatosis in the era of modern chemotherapy.
    Zani S; Papalezova K; Stinnett S; Tyler D; Hsu D; Blazer DG
    J Surg Oncol; 2013 Mar; 107(4):307-11. PubMed ID: 22811275
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: prognosis and treatment of recurrences in a cohort study.
    Cashin PH; Graf W; Nygren P; Mahteme H
    Eur J Surg Oncol; 2012 Jun; 38(6):509-15. PubMed ID: 22475555
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Combined cytoreductive surgery and intraoperative hyperthermic chemo-perfusion for peritoneal carcinomatosis: methods, postoperative features and end results].
    Tarasov VA; Vinogradova MV; Norbaev ShE; Sharov IuK; Stavrovietskiĭ VV; Adueva SA; Blium MB
    Vopr Onkol; 2006; 52(6):638-42. PubMed ID: 17338240
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: postoperative and long-term results.
    Golse N; Bakrin N; Passot G; Mohamed F; Vaudoyer D; Gilly FN; Glehen O; Cotte E
    J Surg Oncol; 2012 Aug; 106(2):197-203. PubMed ID: 22331814
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictors of Severe Morbidity After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Patients With Colorectal Peritoneal Carcinomatosis.
    Simkens GA; van Oudheusden TR; Luyer MD; Nienhuijs SW; Nieuwenhuijzen GA; Rutten HJ; de Hingh IH
    Ann Surg Oncol; 2016 Mar; 23(3):833-41. PubMed ID: 26442921
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Second-look surgery plus HIPEC for patients with colorectal cancer at high risk of peritoneal carcinomatosis: Should we resect the initial anastomosis? An observational study.
    Cloutier AS; Faron M; Honoré C; Goéré D; Dumont F; Vittadello F; Élias D
    Eur J Surg Oncol; 2015 Aug; 41(8):1068-73. PubMed ID: 25921674
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) delivered via a modified perfusion system for peritoneal carcinomatosis of colorectal origin.
    Cravioto-Villanueva A; Cavazos M; Luna-Perez P; Martinez-Gomez H; Ramirez ML; Solorzano J; Montiel H; Esquivel J
    Surg Today; 2016 Aug; 46(8):979-84. PubMed ID: 27138212
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Secondary cytoreductive surgery and peri-operative intraperitoneal chemotherapy for peritoneal recurrence of colorectal and appendiceal peritoneal carcinomatosis following prior primary cytoreduction.
    Klaver YL; Chua TC; Verwaal VJ; de Hingh IH; Morris DL
    J Surg Oncol; 2013 May; 107(6):585-90. PubMed ID: 23280508
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Cytoreductive surgery and HIPEC for peritoneal malignancies in children].
    Seitz G; Fuchs J; Königsrainer I; Warmann SW; Königsrainer A; Beckert S
    Zentralbl Chir; 2014 Dec; 139(6):607-12. PubMed ID: 25531634
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Benefits of metastasectomy for colorectal cancer.
    Cecil T; Mohamed F; Moran B
    BMJ; 2014 Jun; 348():g4033. PubMed ID: 24944123
    [No Abstract]   [Full Text] [Related]  

  • 52. [Preliminary experience with hyperthermic intraperitoneal chemo-perfusion with oxaliplatin for the treatment of peritoneal carcinomatosis due to colorectal carcinoma].
    Mura G; Framarini M; Vagliasindi A; Cavaliere D; Tauceri F; Solfrini G; Milandria C; Verdecchia GM
    Chir Ital; 2007; 59(2):217-23. PubMed ID: 17500178
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Integrated therapeutic strategy in large bowel neoplastic occlusion. An innovative therapeutic protocol].
    Gattai R; Mascitelli EM; Bechi P; Pace M
    Ann Ital Chir; 2007; 78(4):295-301. PubMed ID: 17990604
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytoreductive surgery and HIPEC in treatment of colorectal peritoneal carcinomatosis: experiment or standard care? A survey among oncologic surgeons and medical oncologists.
    Braam HJ; Boerma D; Wiezer MJ; van Ramshorst B
    Int J Clin Oncol; 2015 Oct; 20(5):928-34. PubMed ID: 25788217
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment failure following complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from colorectal or appendiceal mucinous neoplasms.
    Bijelic L; Yan TD; Sugarbaker PH
    J Surg Oncol; 2008 Sep; 98(4):295-9. PubMed ID: 18726900
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intraperitoneal chemotherapy hyperthermia (HIPEC) for peritoneal carcinomatosis of ovarian cancer origin by fluid and CO2 recirculation using the closed abdomen technique (PRS-1.0 Combat): A clinical pilot study.
    Sánchez-García S; Villarejo-Campos P; Padilla-Valverde D; Amo-Salas M; Martín-Fernández J
    Int J Hyperthermia; 2016 Aug; 32(5):488-95. PubMed ID: 27056558
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases: Systematic review of all literature and meta-analysis of observational studies.
    de Cuba EM; Kwakman R; Knol DL; Bonjer HJ; Meijer GA; Te Velde EA
    Cancer Treat Rev; 2013 Jun; 39(4):321-7. PubMed ID: 23244778
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Peritonectomy and hyperthermic antiblastic perfusion in the treatment of peritoneal carcinomatosis.
    Cavaliere F; Di Filippo F; Botti C; Cosimelli M; Giannarelli D; Aloe L; Arcuri E; Aromatario C; Consolo S; Callopoli A; Laurenzi L; Tedesco M; Di Angelo P; Giunta S; Cavaliere R
    Eur J Surg Oncol; 2000 Aug; 26(5):486-91. PubMed ID: 11016471
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of surgical and clinical factors on the pharmacology of intraperitoneal doxorubicin in 145 patients with peritoneal carcinomatosis.
    Sugarbaker PH; Van der Speeten K; Anthony Stuart O; Chang D
    Eur J Surg Oncol; 2011 Aug; 37(8):719-26. PubMed ID: 21621952
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Immediate intraperitoneal chemotherapy after surgery for the reduction of peritoneal malignancies: for what purpose and for whom?].
    Elias D
    Ann Chir; 1995; 49(7):567-72. PubMed ID: 8554266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.